Subscribe
fda-1
carmendorin / iStockphoto.com
14 September 2017Americas

FDA clears orphan drug backlog

The Food and Drugs Administration (FDA) has cleared the backlog of orphan drug designation requests, one month early.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FDA reveals further steps to encourage generic competition
3 January 2018   The US Food and Drug Administration revealed additional steps aimed at encouraging generic competition today.
Americas
FDA introduces orphan drug pilot scheme
28 February 2018   The US Food and Drug Administration has introduced a pilot scheme for processing orphan designation requests more efficiently, as part of its commitment to support and expedite the development of rare disease products.
Big Pharma
House passes Biden-backed orphan drug reform
23 May 2021   The US House of Representatives has passed a bill to amend exclusivity laws for drugs on the US Food and Drug Administration’s orphan drugs list.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
FDA reveals further steps to encourage generic competition
3 January 2018   The US Food and Drug Administration revealed additional steps aimed at encouraging generic competition today.
Americas
FDA introduces orphan drug pilot scheme
28 February 2018   The US Food and Drug Administration has introduced a pilot scheme for processing orphan designation requests more efficiently, as part of its commitment to support and expedite the development of rare disease products.
Big Pharma
House passes Biden-backed orphan drug reform
23 May 2021   The US House of Representatives has passed a bill to amend exclusivity laws for drugs on the US Food and Drug Administration’s orphan drugs list.

More on this story

Americas
FDA reveals further steps to encourage generic competition
3 January 2018   The US Food and Drug Administration revealed additional steps aimed at encouraging generic competition today.
Americas
FDA introduces orphan drug pilot scheme
28 February 2018   The US Food and Drug Administration has introduced a pilot scheme for processing orphan designation requests more efficiently, as part of its commitment to support and expedite the development of rare disease products.
Big Pharma
House passes Biden-backed orphan drug reform
23 May 2021   The US House of Representatives has passed a bill to amend exclusivity laws for drugs on the US Food and Drug Administration’s orphan drugs list.

More features

Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner